Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × dabrafenib × 30 days × Clear all

Sponsor

Conditions

Melanoma 5 Multiple Myeloma 3 Thyroid Carcinoma, Anaplastic 2 Hematologic Neoplasms 2 Glioma 2 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Lymphoproliferative Disorders 1 Lymphoma 1 Laryngeal Neoplasms 1 Histiocytosis, Langerhans-Cell 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Erdheim-Chester Disease 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Astrocytoma 1

Interventions

Cyclophosphamide 10 fludarabine 8 Rituximab 8 Dexamethasone 8 pembrolizumab 7 venetoclax 5 glofitamab 5 Lenalidomide 5 obinutuzumab 4 Etoposide 4 Calcium Dobesilate 4 pomalidomide 3 Temozolomide 3 Doxorubicin 3 Cytarabine 3 zanubrutinib 2 tocilizumab 2 tisagenlecleucel 2 selinexor 2 ruxolitinib 2 ibrutinib 2 enzalutamide 2 dexamethasone acetate 2 dexamethasone 21-phosphate 2 carfilzomib 2 abemaciclib 2 Vincristine 2 Surgical Procedures, Operative 2 Radiotherapy 2 Prednisone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡